Nature

Progesterone elevation on the day of hCG trigger has detrimental effect on live birth rate in low and intermediate ovarian responders, but not in high responders

Progesterone elevation (PE) on the day of hCG trigger is associated with decreased pregnancy outcome in fresh cycles. Evidence for this comes from overall patient estimates that mostly ignore ...
Original paper

Half-dose, long-acting gonadotropin-releasing hormone agonist (Diphereline) is comparable with daily injections of short-acting gonadotropin-releasing hormone agonist ...

Introduction : The aim of the study was to compare the efficacy of half-dose, long-acting GnRH analogue (Diphereline) with Suprefact in IVF/ICSI (in vitro ...
FiercePharma

Ipsen and Invida Enter into a Partnership for the Commercialization of Ipsen's Specialty Care Drugs in South-East Asia

-- Diphereline(R)1, Somatuline(R) Autogel(R) and Increlex(R) to be Commercialized by Invida in Certain Asian Countries Ipsen, a global biopharmaceutical group, and Invida Group, the leading healthcare ...
GEN

Invida to Commercialize Three Ipsen Drugs in Asia Pacific Countries

Deal covers oncology and endocrinology products Diphereline, Somatuline Autogel, and Increlex. Invida negotiated exclusive distribution and promotion rights to a number of Ipsen’s endocrinology and ...
BioSpace

Ipsen and Invida Enter into a Partnership for the Commercialization of Ipsen’s Specialty Care Drugs in South-East Asia

PARIS & SINGAPORE--(BUSINESS WIRE)--Ipsen (Euronext: FR0010259150; IPN), a global biopharmaceutical group, and Invida Group, the leading healthcare commercialization solutions partner in the Asia ...